מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL
Phebra Pty Ltd
Injection, intravenous infusion
Excipient Ingredients: water for injections
Intravenous
10mL x 10
Not scheduled. Not considered by committee
INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.
Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1991-10-14